![ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] logo](/_assets/images/ELO_Logo_4c.svg){kind=logo}
Up to 80% of bleeds occur in the joints.1 Good thing ELOCTATE knows a thing or two.
1.6 median overall bleeds per year†
0 median joint bleeds per year†
~100% of target joints resolved in adults and adolescents treating with ELOCTATE prophylaxis‡
#1 prescribed extended half-life Factor VIII in the US 2
Talk to your doctor to see if ELOCTATE is right for you.
*ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.
†In the A-LONG study, 164 adults and adolescents ages 12-65 received ELOCTATE either every 3 to 5 days, once weekly, or on demand. The ASPIRE extension study included 150 people who completed A-LONG.
‡Data from patients treating prophylactically with ELOCTATE for at least 12 months, who had target joints at enrollment in ASPIRE. 234 out of 235 target joints were resolved. A target joint is defined as a major joint with 3 or more bleeding episodes in a consecutive 6-month period. Target joint resolution is defined as 2 or fewer spontaneous bleeds in a 12-month period.
1Srivastava A, Brewer AK, Mauser- Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 013;19:e1-47.
2#1 prescribed based on HTC reported data as of June 2020.
Sanofi Genzyme Hemophilia Community Relations and Education (CoRe) Managers offer education to people living with hemophilia and their families. CoRe Managers provide information about living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe team member nearest you.
Let's stay in touch. We’ll occasionally send you important information on Hemophilia A and ELOCTATE. If you're new to ELOCTATE, we’ll send you a Bluetooth® speaker so you can listen to patient stories, or if you're already on ELOCTATE, we’ll send you this stylish cooler bag.
Whether you’re a total newbie or a total pro, there’s something to learn about ELOCTATE.
Pick your path below, then select the links to get going.
You know you're leaving the ELOCTATE website?
If you're okay with that, we're okay with that.
Come back soon!
You’re being directed to the ELOCTATE Healthcare Professional website. If you’re okay with that, we’re okay with that.
Come back soon!
INDICATION ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery.
Important Safety Information and Indication INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES
IMPORTANT SAFETY INFORMATION INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES
Do not use ELOCTATE if you have had an allergic reaction to it in the past. No use ELOCTATE si ha tenido una reacción alérgica a este en el pasado.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII. Informe a su proveedor de atención médica si tiene o ha tenido algún problema médico; toma algún medicamento, incluidos medicamentos recetados y de venta libre, suplementos o medicamentos a base de hierbas; tiene alergias; está en período de lactancia; está embarazada o tiene intención de quedar embarazada; o si le han indicado que tiene inhibidores (anticuerpos) del factor VIII.
INDICATION INDICACIONES
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery. ELOCTATE® es un medicamento inyectable que se usa para ayudar a controlar y prevenir la hemorragia en personas con hemofilia A (deficiencia congénita del factor VIII). Su proveedor de atención médica le podría recetar ELOCTATE cuando se opere.
Important Safety Information and Indication INFORMACIÓN DE SEGURIDAD IMPORTANTE INDICACIONES
IMPORTANT SAFETY INFORMATION INFORMACIÓN DE SEGURIDAD
Do not use ELOCTATE if you have had an allergic reaction to it in the past. No use ELOCTATE si ha tenido una reacción alérgica a este en el pasado.
Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII. Informe a su proveedor de atención médica si tiene o ha tenido algún problema médico; toma algún medicamento, incluidos medicamentos recetados y de venta libre, suplementos o medicamentos a base de hierbas; tiene alergias; está en período de lactancia; está embarazada o tiene intención de quedar embarazada; o si le han indicado que tiene inhibidores (anticuerpos) del factor VIII.
Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives. Pueden producirse reacciones alérgicas con ELOCTATE. Llame a su proveedor de atención médica o busque tratamiento de emergencia inmediatamente si presenta alguno de los siguientes síntomas: dificultad para respirar, opresión en el pecho, hinchazón de la cara, erupciones o urticaria.
Your body can also make antibodies called "inhibitors" against ELOCTATE, which may stop ELOCTATE from working properly. Su organismo también puede producir anticuerpos denominados “inhibidores” contra ELOCTATE, que pueden impedir que este actúe correctamente.
Additional common side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. Los efectos secundarios frecuentes adicionales de ELOCTATE son dolor de cabeza, erupciones, dolor articular, dolor muscular y malestar general.
If you have risk factors for developing abnormal blood clots in your body, such as an indwelling venous catheter, treatment with Factor VIII may increase this risk. Si tiene factores de riesgo para el desarrollo de coágulos sanguíneos anómalos en su cuerpo, como un catéter venoso permanente, es posible que el tratamiento con factor VIII aumente este riesgo.
These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, or if bleeding is not controlled after using ELOCTATE. Estos no son todos los efectos secundarios posibles de ELOCTATE. Hable inmediatamente con su proveedor de atención médica sobre cualquier efecto secundario que le moleste o persista, o si la hemorragia no se controla después de usar ELOCTATE.
INDICATION INDICACIONES
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency). Your healthcare provider may give you ELOCTATE when you have surgery. ELOCTATE® es un medicamento inyectable que se usa para ayudar a controlar y prevenir la hemorragia en personas con hemofilia A (deficiencia congénita del factor VIII). Su proveedor de atención médica le podría recetar ELOCTATE cuando se opere.
Please see Full Prescribing Information
CONSULTE LA INFORMACIÓN DE PRESCRIPCIÓN COMPLETA en inglés
POR FAVOR VER LA INFORMACIÓN DEPRESCRIPCIÓN COMPLETA en español
MANUFACTURED BY FABRICADO PARA
Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA Waltham, MA 02451 EE. UU.
U.S. License #2078 U.S. Licencia #2078
Click here to learn more about Sanofi's commitment to fighting counterfeit drugs. HAGA CLIC AQUÍ PARA OBTENER MÁS INFORMACIÓN SOBRE EL COMPROMISO DE SANOFI PARA COMBATIR LOS MEDICAMENTOS FALSIFICADOS.
![ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] logo](/_assets/images/elo-logo.svg){kind=logo}
Education Managers